Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.

about

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.

Item

http://www.wikidata.org/entity/Q44340121

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Phase II trial of subcutaneous ...... atients: an exploratory study.

@en

Phase II trial of subcutaneous ...... re opioid-induced constipation

@nl

type

Item

label

Phase II trial of subcutaneous ...... atients: an exploratory study.

@en

Phase II trial of subcutaneous ...... re opioid-induced constipation

@nl

prefLabel

Phase II trial of subcutaneous ...... atients: an exploratory study.

@en

Phase II trial of subcutaneous ...... re opioid-induced constipation

@nl

P1476

Phase II trial of subcutaneous ...... atients: an exploratory study.

@en

P2093

Masanori Mori

http://www.w3.org/2001/XMLSchema#string

Santosh Kumar

http://www.w3.org/2001/XMLSchema#string

Steven Ades

http://www.w3.org/2001/XMLSchema#string

Takamaru Ashikaga

http://www.w3.org/2001/XMLSchema#string

Yongli Ji

http://www.w3.org/2001/XMLSchema#string

P2860

Laxatives or methylnaltrexone for the management of constipation in palliative care patients

Mu-opioid antagonists for opioid-induced bowel dysfunction

The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer

Early palliative care for patients with metastatic non-small-cell lung cancer

Methylnaltrexone for opioid-induced constipation in advanced illness.

Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.

Increased μ-opioid receptor expression in metastatic lung cancer

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

Strategies to manage the adverse effects of oral morphine: an evidence-based report.

American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.

P2888

s10147-016-1041-6

P304

397-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-016-1041-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27628064

http://www.w3.org/2001/XMLSchema#string

P921

opioid

phase II clinical trial